GBIO Generation Bio Co.

Nasdaq generationbio.com


$ 6.17 $ -0.46 (-6.93 %)    

Friday, 17-Oct-2025 15:59:50 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 6.18
$ 6.64
$ 6.01 x 1
$ 6.95 x 121
$ 6.12 - $ 6.47
$ 3.00 - $ 25.70
31,149
na
41.63M
$ 1.84
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-06-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-13-2024 03-31-2024 10-Q
7 03-06-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 02-23-2023 12-31-2022 10-K
12 11-03-2022 09-30-2022 10-Q
13 08-04-2022 06-30-2022 10-Q
14 05-05-2022 03-31-2022 10-Q
15 02-24-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-11-2021 06-30-2021 10-Q
18 05-12-2021 03-31-2021 10-Q
19 03-18-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-11-2020 06-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-buy-on-generation-bio-maintains-15-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $15 price target.

 wedbush-downgrades-generation-bio-to-neutral-maintains-price-target-to-7

Wedbush analyst David Nierengarten downgrades Generation Bio (NASDAQ:GBIO) from Outperform to Neutral and maintains the pric...

 why-sapiens-international-shares-are-trading-higher-by-around-44-here-are-20-stocks-moving-premarket

Shares of Sapiens International Corporation NV (NASDAQ:SPNS) rose sharply in pre-market trading after it announced on Wednesday...

 generation-bio-q2-eps-312-misses-262-estimate-sales-765000k-miss-2139m-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(3.12) per share which missed the analyst consensus estimate of $(2....

 generation-bio-has-been-granted-australian-patent-number-2019210034-titled-closed-ended-dna-vectors-obtainable-from-cell-free-synthesis-and-process-for-obtaining-cedna-vectors-for-gene-therapy

https://ipsearch.ipaustralia.gov.au/patents/2019210034

 needham-reiterates-buy-on-generation-bio-maintains-8-price-target

Needham analyst Gil Blum reiterates Generation Bio (NASDAQ:GBIO) with a Buy and maintains $8 price target.

 generation-bio-q1-eps-022-beats-029-estimate-sales-872m-beat-213m-estimate

Generation Bio (NASDAQ:GBIO) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.29...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION